ATHE Stock Price Chart
ATHE Price
Alterity Therapeutics Limited
$4.45
-1.87%
$-0.08
At close: Aug 07, 16:00:00 GMT-4
$4.72
6.06%
$0.26
Post-market: Aug 07, 20:00:00 GMT-4
Back
Alterity Therapeutics Limited (ATHE) Price
Key Stats
Prev.Close
$4.53
Open
$4.54
Day's Range
$4.39 - $4.72
52 week range
$2.66 - $5.89
Volume
1.3K
Avg.Volume
45.5K
Dividend yield
--
EPS (TTM)
-0.56
Market Cap
$85.5M
What is Alterity Therapeutics Limited?
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 10 full-time employees. The company went IPO on 2000-03-28. The firm is focused on developing disease modifying treatments for neurodegenerative diseases. The firm's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The firm also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.
